Symeres

Symeres is a prominent European contract research organization (CRO) formed through the strategic fusion of four established European CROs. Founded in 1988, the company operates within the business services sector, specializing in comprehensive drug discovery and development services for the pharmaceutical and biotechnology industries. Its core offerings encompass a range of R&D services, from early-stage drug discovery and medicinal chemistry to preclinical development and clinical stage support, positioning it as a key partner in advancing novel therapeutics. The company boasts a significant operational scale, employing approximately 500 scientists across six distinct locations in Europe, including Groningen, Nijmegen, and Weert in the Netherlands, Prague in the Czech Republic, Oulu in Finland, and Södertälje in Sweden. This extensive network of facilities and expertise supports its mission to deliver best-in-class R&D services. Symeres leverages its multicultural workforce and scientific talent to drive innovation in drug development. Meet Symeres's team to understand the depth of expertise contributing to their client projects. The company's employee range is between 500 - 1,000 employees, reflecting its substantial operational capacity. Symeres generates an annual revenue of $15.8M, underscoring its financial standing within the competitive CRO market. The company's strategic focus on providing high-quality contract research and development services positions it as a vital contributor to the global pharmaceutical pipeline, facilitating the progression of small molecule drugs from discovery through to clinical stages.